A Cell Press partner journal
 
Related commentsú║
 
Add comment (English only)
Name*:
E-mail:
Telephone:
Code:  
Comments*:
 Position: Home > issue > The 2nd Issue  
Current status and future perspective of immunotherapy in gastrointestinal cancers
Category: Review
Author: Zhihao Lu

╦Đ╣ĚŻě═╝20�?8�?2�?816_3.jpg

Current status and future perspective of immunotherapy in gastrointe


Gastrointestinal (GI) cancers represent a major public health problemworldwide. Due to the late detection and high heterogeneity of GI cancers, traditional treatments, including surgery, radiotherapy, chemotherapy and targetedtherapy have shown limited effects and the overall prognosis of these patientsremains poor. Recently, immunotherapy,involving programmed cell death-1 (PD-1) and its ligand (PD-L1), has shown promising efficacy in several solid cancers, and seems to become a potential treatment option for GI cancers This review focuses on data on the development of immunotherapy-based clinical trials in esophageal cancer, gastric cancer (GC) and colorectal cancer(CRC).





[Printing]  [Close
Host:   Academic co-partner: Stay connected:
    SHANGHAI INSTITUTE OF APPLIED PHYSICS, CAS

  inquiry@the-innovation.org
  the.innovation.journal
  the.innovation.journal
  The_InnovationJ
  The Innovation┤┤đ┬
  The Innovation┤┤đ┬

Publishing partner:   INSTITUTE OF MICROBIOLOGY, CAS
  XI'AN INSTITUTE OF OPTICS AND PRECISION MECHANICS, CAS
  Copyright © 2019-2020 the-innovation.org All Rights Reserved